Identification of Binding Specificity-Determining Features in Protein Families

被引:3
作者
Anderson, Peter C. [1 ]
De Sapio, Vincent [2 ]
Turner, Kevin B. [1 ]
Elmer, Sidney P. [1 ]
Roe, Diana C. [1 ]
Schoeniger, Joseph S. [1 ]
机构
[1] Sandia Natl Labs, Livermore, CA 94551 USA
[2] HRL Labs LLC, Informat & Syst Sci Lab, Malibu, CA 90265 USA
关键词
MULTIPLE SEQUENCE ALIGNMENT; KINASE INHIBITORS; DRUG DESIGN; RECEPTOR INTERACTIONS; MOLECULAR RECOGNITION; STRUCTURAL BIOLOGY; LIGAND SELECTIVITY; COUPLED RECEPTORS; LEAD DISCOVERY; CROSS-DOCKING;
D O I
10.1021/jm200979x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We present a new approach for identifying features of ligand-protein binding interfaces that predict binding selectivity and demonstrate its effectiveness for predicting kinase inhibitor specificity. We analyzed a large set of human kinases and kinase inhibitors using clustering of experimentally determined inhibition constants (to define specificity classes of kinases and inhibitors) and virtual ligand docking (to extract structural and chemical features of the ligand protein binding interfaces). We then used statistical methods to identify features characteristic of each class. Machine learning was employed to determine which combinations of characteristic features were predictive of class membership and to predict binding specificities and affinities of new compounds. Experiments showed predictions were 70% accurate. These results show that our method can automatically pinpoint on the three-dimensional binding interfaces pharmacophore-like features that act as "selectivity filters". The method is not restricted to kinases, requires no prior hypotheses about specific interactions, and can be applied to any protein families for which sets of structures and ligand binding data are available.
引用
收藏
页码:1926 / 1939
页数:14
相关论文
共 67 条
[1]   Novel immunotherapies for psoriasis [J].
Asadullah, K ;
Volk, HD ;
Sterry, W .
TRENDS IN IMMUNOLOGY, 2002, 23 (01) :47-53
[2]   The selectivity of protein kinase inhibitors: a further update [J].
Bain, Jenny ;
Plater, Lorna ;
Elliott, Matt ;
Shpiro, Natalia ;
Hastie, C. James ;
Mclauchlan, Hilary ;
Klevernic, Iva ;
Arthur, J. Simon C. ;
Alessi, Dario R. ;
Cohen, Philip .
BIOCHEMICAL JOURNAL, 2007, 408 :297-315
[3]   Assessment of Chemical Coverage of Kinome Space and Its Implications for Kinase Drug Discovery [J].
Bamborough, Paul ;
Drewry, David ;
Harper, Gavin ;
Smith, Gary K. ;
Schneider, Klaus .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (24) :7898-7914
[4]   Chemogenomics: An emerging strategy for rapid target and drug discovery [J].
Bredel, M ;
Jacoby, E .
NATURE REVIEWS GENETICS, 2004, 5 (04) :262-275
[5]   Fragment-based lead discovery: leads by design [J].
Carr, RAE ;
Congreve, M ;
Murray, CW ;
Rees, DC .
DRUG DISCOVERY TODAY, 2005, 10 (14) :987-992
[6]   Multiple sequence alignment with the Clustal series of programs [J].
Chenna, R ;
Sugawara, H ;
Koike, T ;
Lopez, R ;
Gibson, TJ ;
Higgins, DG ;
Thompson, JD .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3497-3500
[7]   The development and therapeutic potential of protein kinase inhibitors [J].
Cohen, P .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (04) :459-465
[8]   Unraveling hot spots in binding interfaces: progress and challenges [J].
DeLano, WL .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2002, 12 (01) :14-20
[9]   Structural interaction fingerprint (SIFt): A novel method for analyzing three-dimensional protein-ligand binding interactions [J].
Deng, Z ;
Chuaqui, C ;
Singh, J .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (02) :337-344
[10]   Large-Scale Structural Biology of the Human Proteome [J].
Edwards, Aled .
ANNUAL REVIEW OF BIOCHEMISTRY, 2009, 78 :541-568